MEDICINOVA INC cotiza a 1.54 USD y tiene una capitalización bursátil de $76M. En los últimos 12 meses ha facturado $920481 con un margen de flujo de caja libre del -2395.4%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. It develops MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent in Phase 2 clinical trial for treating neuro…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | — | $-0.05 | $-0.05 |
| Estimado | $-9.40 | $-10.43 | $-0.06 | $-0.09 |
| Sorpresa | — | — | +16.7% | +44.4% |
| Métrica | MNOV | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | -3242.5% | -38.6% | -3203.8% |
| Net Margin | -2928.8% | -33.6% | -2895.2% |
| FCF Margin | -2395.4% | -13.9% | -2381.5% |
| ROE | -28.9% | -40.4% | +11.5% |
| ROA | -26.3% | -32.0% | +5.7% |
| Current Ratio | 8.16 | 2.84 | +5.32 |
| Debt / Equity | — | 0.28 | — |